Rockefeller Financial Services’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | $1.02M | Hold |
|
|||||
|
2017
Q3 | $1.2M | Hold |
|
|||||
|
2017
Q2 | $1.04M | Sell |
|
|||||
|
2017
Q1 | $1.12M | Hold |
|
|||||
|
2016
Q4 | $1.13M | Hold |
|
|||||
|
2016
Q3 | $1.13M | Hold |
|
|||||
|
2016
Q2 | $1.08M | Hold |
|
|||||
|
2016
Q1 | $1.29M | Sell |
|
|||||
|
2015
Q4 | $2.32M | Sell |
|
|||||
|
2015
Q3 | $2.38M | Sell |
|
|||||
|
2015
Q2 | $44.4M | Buy |
|
|||||
|
2015
Q1 | $34.1M | Buy |
|
|||||
|
2014
Q4 | $34.8M | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $37.7M | Sell |
|
|||||
|
2014
Q1 | $53.3M | Buy |
|
|||||
|
2013
Q4 | $46.3M | Sell |
|
|||||
|
2013
Q3 | $53.2M | Sell |
|
|||||
|
2013
Q2 | $46.8M | Buy |
|